Sebastiaan J. Trietsch, PhD (he/him/his)

Chief Technology Officer
Mimetas BV, Netherlands

Dr. Bas Trietsch, is the CTO and co-founder of MIMETAS. He is co-inventor of the OrganoPlate®, optimized it towards a mass manufacturable product and enabled the establishment of MIMETAS’ production facility. He developed the initial tissue models on the OrganoPlate and continues to support assay development in the OrganoPlate. As CTO he currently drives product development and grows Mimetas' tissue production, HTS based drug discovery and data science capabilities. Bas holds a Ph.D. in biopharmaceutical sciences from Leiden University and co-authored over 50 peer-reviewed publications and patents.

Poster(s):

• (1013-B) An vascularized melanoma model for with unidirectional perfusion of circulating immune cells for Advancing Immune-Oncology Research
  Monday, February 5, 2024

  2:00 PM – 3:00 PM EST